Q-omics provides the consensus-scored TXNL4AP1 profile across patient tissues and cancer cell-line models. TXNL4AP1 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in LUAD. Additionally, TXNL4AP1 RNA expression shows 7,968 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight LUAD, and GBM as cancer lineages where TXNL4AP1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.